Dairy products and prevention of type 2 diabetes: Implications for research and practice

Frontiers in Endocrinology

Volumn 4, Issue JUL, 2013, Pages

  Kalergis, Maria ^a   Leung Yinko, Sylvie S L ^b   Nedelcu, Roxana ^c  

^a Dairy Farmers of Canada   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Dairy; Dairy products; Diabetes; Metabolic syndrome; Milk; T2D

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANS PALMITOLEIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VITAMIN D;

BODY WEIGHT; DAIRY PRODUCT; DIETARY INTAKE; DISEASE ASSOCIATION; DOWN REGULATION; FAT INTAKE; HUMAN; LIPID DIET; LOW FAT DIET; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; SHORT SURVEY; SYSTEMATIC REVIEW (TOPIC); UPREGULATION;

EID: 84884171205     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00090     Document Type: Short Survey

References (45)

1. International Diabetes Federation. IDF Diabetes Atlas Update 2012. 5th ed. (2012). Available from: http://www.idf.org/
2. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes (2008) 32:S1-201.
3. Krebs-Smith SM, Guenther PM, Subar AF, Kirkpatrick SI, Dodd KW. Americans do not meet federal dietary recommendations. J Nutr (2010) 140:1832-8. doi:10.3945/jn.110.124826
4. Garriguet D. Canadians' eating habits. Health Rep (2007) 18:17-32.
5. Vandevijvere S, De Vriese S, Huybrechts I, Moreau M, Temme E, De Henauw S, et al. The gap between food-based dietary guidelines and usual food consumption in Belgium, 2004. Public Health Nutr (2009) 12:423-31. doi:10.1017/S1368980008002164
6. Liu AD, Zhang B, Du WW, Wang HJ, Su C, Zhai FY. [Milk consumption and its changing trend of Chinese adult aged 18 - 44 in nine provinces (autonomous region) from 1991 to 2006]. Zhonghua Yu Fang Yi Xue Za Zhi (2011) 45:304-9.
7. Doidge JC, Segal L. Most Australians do not meet recommendations for dairy consumption: findings of a new technique to analyse nutrition surveys. Aust N Z J Public Health (2012) 36:236-40. doi:10.1111/j.1753-6405
8. Tong X, Dong JY, Wu ZW, Li W, Qin LQ. Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies. Eur J Clin Nutr (2011) 65:1027-31. doi:10.1038/ejcn.2011.62
9. Elwood PC, Givens DI, Beswick AD, Fehily AM, Pickering JE, Gallacher J. The survival advantage of milk and dairy consumption: an overview of evidence from cohort studies of vascular diseases, diabetes and cancer. J Am Coll Nutr (2008) 27:723S-34. doi:10.1080/07315724.2008.10719750
10. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab (2007) 92:2017-29. doi:10.1210/jc.2007-0298
11. United States Department of Agriculture. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans 2010 to the Secretary of Health and Human Services and the Secretary of Agriculture. Washington, DC (2010).
12. Grantham NM, Magliano DJ, Hodge A, Jowett J, Meikle P, Shaw JE. The association between dairy food intake and the incidence of diabetes in Australia: the Australian Diabetes Obesity and Lifestyle Study (AusDiab). Public Health Nutr (2013) 16:339-45. doi:10.1017/S1368980012001310
13. Louie JC, Flood VM, Rangan AM, Burlutsky G, Gill TP, Gopinath B, et al. Higher regular fat dairy consumption is associated with lower incidence of metabolic syndrome but not type 2 diabetes. Nutr Metab Cardiovasc Dis (2012). doi:10.1016/j.numecd.2012.08.004
14. Struijk EA, Heraclides A, Witte DR, Soedamah-Muthu SS, Geleijnse JM, Toft U, et al. Dairy product intake in relation to glucose regulation indices and risk of type 2 diabetes. Nutr Metab Cardiovasc Dis (2012). doi:10.1016/j.numecd.2012.05.011
15. Soedamah-Muthu SS, Masset G, Verberne L, Geleijnse JM, Brunner EJ. Consumption of dairy products and associations with incident diabetes, CHD and mortality in the Whitehall II study. Br J Nutr (2012) 109:718-26. doi:10.1017/S0007114512001845
16. Fumeron F, Lamri A, Abi Khalil C, Jaziri R, Porchay-Balderelli I, Lantieri O, et al. Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a French prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care (2011) 34:813-7. doi:10.2337/dc10-1772
17. Malik VS, Sun Q, Van Dam RM, Rimm EB, Willett WC, Rosner B, et al. Adolescent dairy product consumption and risk of type 2 diabetes in middle-aged women. Am J Clin Nutr (2011) 94:854-61. doi:10.3945/ajcn.110.009621
18. Sluijs I, Forouhi NG, Beulens JW, van der Schouw YT, Agnoli C, Arriola L, et al. The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study. Am J Clin Nutr (2012) 96:382-90. doi:10.3945/ajcn.111.021907
19. Rideout TC, Marinangeli CP, Martin H, Browne RW, Rempel CB. Consumption of low-fat dairy foods for 6 months improves insulin resistance without adversely affecting lipids or bodyweight in healthy adults: a randomized free-living cross-over study. Nutr J (2013) 12:56. doi:10.1186/1475-2891-12-56
20. Kratz M, Baars T, Guyenet S. The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Nutr (2013) 52:1-24. doi:10.1007/s00394-012-0418-1
21. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, et al. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med (2010) 153:790-9. doi:10.7326/0003-4819-153-12-201012210-00005
22. Mozaffarian D, De Oliveira Otto MC, Lemaitre RN, Fretts AM, Hotamisligil G, Tsai MY, et al. trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr (2013) 97(4):854-61. doi:10.3945/ajcn.112.045468
23. Abargouei AS, Janghorbani M, Salehi-Marzijarani M, Esmaillzadeh A. Effect of dairy consumption on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials. Int J Obes (Lond) (2012) 36:1485-93. doi:10.1038/ijo.2011.269
24. Chen M, Pan A, Malik VS, Hu FB. Effects of dairy intake on body weight and fat: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2012) 96:735-47. doi:10.3945/ajcn.112.037119
25. Louie JC, Flood VM, Hector DJ, Rangan AM, Gill TP. Dairy consumption and overweight and obesity: a systematic review of prospective cohort studies. Obes Rev (2011) 12:e582-92. doi:10.1111/j.1467-789X.2011.00881.x
26. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med (2011) 364:2392-404. doi:10.1056/NEJMoa1014296
27. Zemel MB. The role of dairy foods in weight management. J Am Coll Nutr (2005) 24:537S-46. doi:10.1080/07315724.2005.10719502
28. Christensen R, Lorenzen JK, Svith CR, Bartels EM, Melanson EL, Saris WH, et al. Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev (2009) 10:475-86. doi:10.1111/j.1467-789X.2009.00599.x
29. Gonzalez JT, Rumbold PL, Stevenson EJ. Effect of calcium intake on fat oxidation in adults: a meta-analysis of randomized, controlled trials. Obes Rev (2012) 13:848-57. doi:10.1111/j.1467-789X.2012.01013.x
30. Pihlanto-Leppala A, Koskinen P, Piilola K, Tupasela T, Korhonen H. Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. J Dairy Res (2000) 67:53-64. doi:10.1017/S0022029999003982
31. Pal S, Ellis V, Dhaliwal S. Effects of whey protein isolate on body composition, lipids, insulin and glucose in overweight and obese individuals. Br J Nutr (2010) 104:716-23. doi:10.1017/S0007114510000991
32. Crichton GE, Bryan J, Buckley J, Murphy KJ. Dairy consumption and metabolic syndrome: a systematic review of findings and methodological issues. Obes Rev (2011) 12:e190-201. doi:10.1111/j.1467-789X.2010.00837.x
33. Ojuka EO. Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc Nutr Soc (2004) 63:275-8. doi:10.1079/PNS2004339
34. Wright DC, Hucker KA, Holloszy JO, Han DH. Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes (2004) 53:330-5. doi:10.2337/diabetes.53.2.330
35. Zemel MB. Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension. Mol Cell Biochem (1998) 188:129-36. doi:10.1023/A:1006880708475
36. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB J (2000) 14:1132-8.
37. Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, Squires PE, et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol (2004) 89-90:121-5. doi:10.1016/j.jsbmb.2004.03.115
38. Maestro B, Campion J, Davila N, Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J (2000) 47:383-91. doi:10.1507/endocrj.47.383
39. Dunlop TW, Vaisanen S, Frank C, Molnar F, Sinkkonen L, Carlberg C. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol (2005) 349:248-60. doi:10.1016/j.jmb.2005.03.060
40. Luquet S, Gaudel C, Holst D, Lopez-Soriano J, Jehl-Pietri C, Fredenrich A, et al. Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes. Biochim Biophys Acta (2005) 1740:313-7. doi:10.1016/j.bbadis.2004.11.011
41. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 286:327-34. doi:10.1001/jama.286.3.327
42. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes (2003) 52:1799-805. doi:10.2337/diabetes.52.7.1799
43. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. J Clin Endocrinol Metab (2004) 89:447-52. doi:10.1210/jc.2003-031005
44. Dimopoulos N, Watson M, Sakamoto K, Hundal HS. Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells. Biochem J (2006) 399:473-81. doi:10.1042/BJ20060244
45. Alhazmi A, Stojanovski E, McEvoy M, Garg ML. Macronutrient intakes and development of type 2 diabetes: a systematic review and meta-analysis of cohort studies. J Am Coll Nutr (2012) 31:243-58. doi:10.1080/07315724.2012.10720425